Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer: A population-based study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer : A population-based study. / Jensen, Pernille T.; Schnack, Tine H.; Frøding, Ligita P.; Bjørn, Signe F.; Lajer, Henrik; Markauskas, Algirdas; Jochumsen, Kirsten M.; Fuglsang, Katrine; Dinesen, Jacob; Søgaard, Charlotte H.; Søgaard-Andersen, Erik; Jensen, Marianne M.; Knudsen, Aage; Øster, Laura H.; Høgdall, Claus.
In: European Journal of Cancer, Vol. 128, 2020, p. 47-56.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer
T2 - A population-based study
AU - Jensen, Pernille T.
AU - Schnack, Tine H.
AU - Frøding, Ligita P.
AU - Bjørn, Signe F.
AU - Lajer, Henrik
AU - Markauskas, Algirdas
AU - Jochumsen, Kirsten M.
AU - Fuglsang, Katrine
AU - Dinesen, Jacob
AU - Søgaard, Charlotte H.
AU - Søgaard-Andersen, Erik
AU - Jensen, Marianne M.
AU - Knudsen, Aage
AU - Øster, Laura H.
AU - Høgdall, Claus
PY - 2020
Y1 - 2020
N2 - Aim: Lately, the safety of minimally invasive surgery (MIS) in the treatment of cervical cancer (CC) has been questioned. This study aimed to evaluate the risk of recurrence and survival after a nationwide adoption of robotic MIS for the treatment of early-stage CC in Denmark. Methods: Population-based data on all Danish women with early-stage CC, who underwent radical hysterectomy January 1st 2005–June 30th 2017 were retrieved from the Danish Gynecologic Cancer Database and enriched with follow-up data on recurrence, death and cause of death. The cohort was divided into two groups according to the year of robotic MIS introduction at each cancer centre. Chi-squared or Fischer test, the Kaplan Meier method and multivariate Cox regression were used for comparison between groups. Results: One thousand one hundred twenty-five patients with CC were included; 530 underwent surgery before (group 1) and 595 underwent surgery after (group 2) the introduction of robotic MIS. The 5-year rate of recurrence was low: 8.2% and 6.3% (p = 0.55) in group 1 and 2, respectively. In adjusted analyses, this corresponded to a five-year disease-free survival, hazard ratio (HR) 1.23 [95% confidence interval (CI) 0.79-1.93]. No difference in site of recurrence (P = 0.19) was observed. The cumulative cancer-specific survival was 94.1% and 95.9% (P = 0.10) in group 1 and 2, respectively, corresponding to a HR 0.60 [95% CI 0.32–1.11] in adjusted analyses. Conclusion: In this population-based cohort study, the Danish nationwide adoption of robotic MIS for early-stage CC was not associated with increased risk of recurrence or reduction in survival outcomes.
AB - Aim: Lately, the safety of minimally invasive surgery (MIS) in the treatment of cervical cancer (CC) has been questioned. This study aimed to evaluate the risk of recurrence and survival after a nationwide adoption of robotic MIS for the treatment of early-stage CC in Denmark. Methods: Population-based data on all Danish women with early-stage CC, who underwent radical hysterectomy January 1st 2005–June 30th 2017 were retrieved from the Danish Gynecologic Cancer Database and enriched with follow-up data on recurrence, death and cause of death. The cohort was divided into two groups according to the year of robotic MIS introduction at each cancer centre. Chi-squared or Fischer test, the Kaplan Meier method and multivariate Cox regression were used for comparison between groups. Results: One thousand one hundred twenty-five patients with CC were included; 530 underwent surgery before (group 1) and 595 underwent surgery after (group 2) the introduction of robotic MIS. The 5-year rate of recurrence was low: 8.2% and 6.3% (p = 0.55) in group 1 and 2, respectively. In adjusted analyses, this corresponded to a five-year disease-free survival, hazard ratio (HR) 1.23 [95% confidence interval (CI) 0.79-1.93]. No difference in site of recurrence (P = 0.19) was observed. The cumulative cancer-specific survival was 94.1% and 95.9% (P = 0.10) in group 1 and 2, respectively, corresponding to a HR 0.60 [95% CI 0.32–1.11] in adjusted analyses. Conclusion: In this population-based cohort study, the Danish nationwide adoption of robotic MIS for early-stage CC was not associated with increased risk of recurrence or reduction in survival outcomes.
KW - Cancer recurrence
KW - Cancer-specific survival
KW - Cervical cancer
KW - Disease-free survival
KW - Minimally invasive surgery
KW - Overall survival
KW - Population-based study
KW - Radical hysterectomy
KW - Robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=85079122269&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2019.12.020
DO - 10.1016/j.ejca.2019.12.020
M3 - Journal article
C2 - 32109850
AN - SCOPUS:85079122269
VL - 128
SP - 47
EP - 56
JO - European Journal of Cancer, Supplement
JF - European Journal of Cancer, Supplement
SN - 0959-8049
ER -
ID: 254733490